196 related articles for article (PubMed ID: 22660213)
1. Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: alternative retinoblastoma treatment.
Darsova D; Pochop P; Uhlik J; Klapkova E; Tesfaye H; Kodetova D; Lestak J; Malis J; Vajner L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):318-23. PubMed ID: 22660213
[TBL] [Abstract][Full Text] [Related]
2. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
3. Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy.
Carcaboso AM; Bramuglia GF; Chantada GL; Fandiño AC; Chiappetta DA; de Davila MT; Rubio MC; Abramson DH
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3761-7. PubMed ID: 17652749
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.
Buitrago E; Höcht C; Chantada G; Fandiño A; Navo E; Abramson DH; Schaiquevich P; Bramuglia GF
Exp Eye Res; 2010 Jul; 91(1):9-14. PubMed ID: 20307538
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal carboplatin concentration and area under concentration versus time curve after intravitreal and periocular delivery.
Pochop P; Darsova D; Kukacka J; Tesfaye H; Vajner L; Uhlik J; Kodetová D; Malis J; Dotrelova D
Eur J Ophthalmol; 2010; 20(4):745-51. PubMed ID: 20306443
[TBL] [Abstract][Full Text] [Related]
6. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
[TBL] [Abstract][Full Text] [Related]
7. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
8. Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: Implications for retinoblastoma treatment.
Del Sole MJ; Clausse M; Nejamkin P; Cancela B; Del Río M; Lamas G; Lubieniecki F; Francis JH; Abramson DH; Chantada G; Schaiquevich P
Exp Eye Res; 2022 May; 218():109026. PubMed ID: 35276184
[TBL] [Abstract][Full Text] [Related]
9. Periocular topotecan for intraocular retinoblastoma.
Mallipatna AC; Dimaras H; Chan HS; Héon E; Gallie BL
Arch Ophthalmol; 2011 Jun; 129(6):738-45. PubMed ID: 21670340
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
[TBL] [Abstract][Full Text] [Related]
11. Is intravitreal topotecan toxic to retinal function?
Nadelmann J; Francis JH; Brodie SE; Muca E; Abramson DH
Br J Ophthalmol; 2021 Jul; 105(7):1016-1018. PubMed ID: 32665221
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
Rao R; Honavar SG; Sharma V; Reddy VAP
Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
[TBL] [Abstract][Full Text] [Related]
13. Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding.
Karl MD; Francis JH; Iyer S; Marr B; Abramson DH
J Pediatr Ophthalmol Strabismus; 2017 May; 54(3):185-190. PubMed ID: 28092395
[TBL] [Abstract][Full Text] [Related]
14. Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
Pascual-Pasto G; Olaciregui NG; Opezzo JAW; Castillo-Ecija H; Cuadrado-Vilanova M; Paco S; Rivero EM; Vila-Ubach M; Restrepo-Perdomo CA; Torrebadell M; Suñol M; Schaiquevich P; Mora J; Bramuglia GF; Chantada GL; Carcaboso AM
J Control Release; 2017 Oct; 264():34-44. PubMed ID: 28830790
[TBL] [Abstract][Full Text] [Related]
15. Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma.
Francis JH; Marr BP; Schaiquevich P; Kellick MG; Abramson DH
Br J Ophthalmol; 2015 Oct; 99(10):1320-2. PubMed ID: 25926516
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits.
Wang M; Liu W; Lu Q; Zeng H; Liu S; Yue Y; Cheng H; Liu Y; Xue M
Retina; 2012; 32(10):2158-64. PubMed ID: 23099451
[TBL] [Abstract][Full Text] [Related]
20. Ocular topotecan pharmacokinetics following topical administration to rabbits for diffused anterior retinoblastoma.
Taich P; Del Sole M; Buontempo F; Williams G; Winter U; Sgroi M; Chantada G; Schaiquevich P
J Pharm Pharmacol; 2017 May; 69(5):574-581. PubMed ID: 27578324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
